A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT.

Bryant JL, Britson J, Balko JM, Willian M, Timmons R, Frolov A, Black EP
Br J Cancer. 2012 106 (1): 148-56

PMID: 22045191 · PMCID: PMC3251842 · DOI:10.1038/bjc.2011.465

MeSH Terms (10)

Antineoplastic Agents Cell Line, Tumor Epithelial-Mesenchymal Transition ErbB Receptors Erlotinib Hydrochloride Gene Expression Profiling Humans MicroRNAs Neoplasms, Glandular and Epithelial Quinazolines

Connections (1)

This publication is referenced by other Labnodes entities: